These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1238 related items for PubMed ID: 6767404

  • 1. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 2. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 01; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Nov 01; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 4. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep 01; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 5. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N.
    Contraception; 1984 Nov 01; 30(5):421-30. PubMed ID: 6440738
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 7. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF, Ng CS, Holck S, Hall PE, Ratnam SS.
    Contraception; 1992 Sep 01; 46(3):227-41. PubMed ID: 1451519
    [Abstract] [Full Text] [Related]

  • 8. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec 01; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 9. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L.
    Contraception; 1983 May 01; 27(5):439-52. PubMed ID: 6349925
    [Abstract] [Full Text] [Related]

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 01; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 11. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 01; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 12. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
    Skouby SO, Wagner HH, Andersen O.
    Contraception; 1983 Nov 01; 28(5):489-99. PubMed ID: 6425010
    [Abstract] [Full Text] [Related]

  • 13. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 01; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun 01; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 15. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun 01; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 16. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 17. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A, Stoy DB, LaRosa JC, Muesing RA, Cleary PA, Miller VT, Gilbert PR, Stadel B.
    Contraception; 1986 Aug 15; 34(2):121-34. PubMed ID: 3096633
    [Abstract] [Full Text] [Related]

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug 15; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [Abstract] [Full Text] [Related]

  • 20. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL, Roy S, Lobo RA.
    Contraception; 1984 Apr 15; 29(4):319-24. PubMed ID: 6235099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.